HOLX Share Price

Open 37.23 Change Price %
High 37.37 1 Day -0.07 -0.19
Low 36.94 1 Week 0.73 2.01
Close 37.01 1 Month -0.52 -1.39
Volume 2340233 1 Year -1.07 -2.81
52 Week High 46.80
52 Week Low 35.15
HOLX Important Levels
Resistance 2 37.41
Resistance 1 37.24
Pivot 37.11
Support 1 36.78
Support 2 36.61
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
RITT 0.04 33.33%
SCHS 0.04 33.33%
RPRX 0.56 27.27%
ATRM 1.73 27.21%
BSDM 0.62 26.53%
TISA 1.63 26.36%
SNTA 0.34 25.93%
OTT 2.39 25.13%
DGLY 2.65 20.45%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
DRRX 0.78 -60.41%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

Hologic, Inc. (NASDAQ: HOLX)

HOLX Technical Analysis 4
As on 20th Oct 2017 HOLX Share Price closed @ 37.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 41.12 & Sell for SHORT-TERM with Stoploss of 37.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
HOLX Target for October
1st Target up-side 38.54
2nd Target up-side 39.83
3rd Target up-side 41.13
1st Target down-side 34.84
2nd Target down-side 33.55
3rd Target down-side 32.25
HOLX Other Details
Segment EQ
Market Capital 5513593344.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.hologic.com
HOLX Address
HOLX
35 Crosby Drive
Bedford, MA 01730
United States
Phone: 781-999-7300
HOLX Latest News
Interactive Technical Analysis Chart Hologic, Inc. ( HOLX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Hologic, Inc.
HOLX Business Profile
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. On August 1, 2012, the Company acquired Gen-Probe Incorporated (Gen-Probe). Gen-Probe is engaged in molecular diagnostics products and services, which are used to diagnose human diseases, screen donated human blood and test transplant compatibility. In March 2013, it announced that it has completed its sale of the LIFECODES business unit to Immucor, Inc.